Canaccord Genuity Group Issues Positive Forecast for WELL Health Technologies (TSE:WELL) Stock Price

WELL Health Technologies (TSE:WELL – Get Free Report) had its target price raised by investment analysts at Canaccord Genuity Group from C$6.50 to C$7.75 in a research note issued to investors on Thursday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would suggest a potential upside of 77.75% from the company’s current price.

WELL has been the topic of several other research reports. Stifel Nicolaus lifted their target price on shares of WELL Health Technologies from C$8.00 to C$8.25 and gave the company a “buy” rating in a report on Wednesday, June 3rd. Canadian Imperial Bank of Commerce lifted their price objective on WELL Health Technologies from C$5.50 to C$6.00 and gave the company an “outperformer” rating in a report on Wednesday, June 3rd. Four investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, WELL Health Technologies has a consensus rating of “Buy” and an average target price of C$7.12.

Get WELL Health Technologies alerts:

View Our Latest Report on WELL Health Technologies

WELL Health Technologies Stock Performance

Shares of TSE WELL traded up C$0.04 during midday trading on Thursday, reaching C$4.36. 792,087 shares of the company were exchanged, compared to its average volume of 1,436,793. The stock has a fifty day simple moving average of C$4.31 and a 200 day simple moving average of C$4.14. WELL Health Technologies has a 1 year low of C$3.58 and a 1 year high of C$6.08. The stock has a market cap of C$1.11 billion, a P/E ratio of 39.64, a PEG ratio of -1.93 and a beta of 0.90. The company has a current ratio of 0.83, a quick ratio of 1.02 and a debt-to-equity ratio of 91.15.

WELL Health Technologies (TSE:WELL – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported C$0.06 EPS for the quarter. The business had revenue of C$368.26 million during the quarter. WELL Health Technologies had a return on equity of 3.15% and a net margin of 1.82%. On average, research analysts forecast that WELL Health Technologies will post 0.3000698 earnings per share for the current fiscal year.

About WELL Health Technologies

(Get Free Report)

WELL Health Technologies Corp. (TSX: WELL) is Canada’s largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services.

Further Reading

• Five stocks we like better than WELL Health Technologies
• PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
• Dollar Tree’s Turnaround Is Starting to Take Root
• Why Levi’s Digital Strategy Is Paying Off in a Big Way
• Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump

Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.